Author

Ipek Celikoyar

Koch Institute for Integrative Cancer Research At MIT

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:drug response / drug discovery· 1 Approach:genetic perturbation / CRISPR· 1 Organism:human· 1

Frequent Co-Authors

Angela N. KoehleriD· 1 shared Arianna Arroyo-Ortega· 1 shared Chi-Chao CheniD· 1 shared Claire Glickman· 1 shared Francisco J. Sánchez RiveraiD· 1 shared Grace A. Johnson· 1 shared Han‐Teo LeeiD· 1 shared Keisuke MotoyamaiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Angela N. KoehlerORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Epigenetic Reactivation of Lineage Differentiation to Target Leukemia

Shandon M Amos, Chi-Chao Chen, Yichen Xiang, Keisuke Motoyama, Tania J González-Robles, Varun K. Narendra, Grace A. Johnson, Han‐Teo Lee, Yu-Jui Ho, Ipek Celikoyar, Ziyang Ye, Shenghao Guo, Claire Glickman, Natalie A. O’Hearn, Oindrila Sarkar, , Yadira M. Soto‐Feliciano

This study identifies TRIM28 as a critical regulator in acute leukemia, showing its depletion promotes neutrophil differentiation and reduces leukemic potential, with a small-molecule inhibitor developed to target it.

bioRxiv · Jul 10, 2026 · PreprintCancer Biology